PK/PD Relationships MCQs With Answer

Introduction: This set of PK/PD Relationships MCQs with answers is designed specifically for M.Pharm students preparing for advanced biopharmaceutics and pharmacokinetics examinations. The questions probe core principles linking pharmacokinetics (what the body does to a drug) and pharmacodynamics (what the drug does to the body), including concentration–effect relationships, PK/PD indices, hysteresis, effect-compartment modeling, indirect response models, and antibiotic PD targets. Each item is crafted to deepen conceptual understanding and analytic thinking required for modeling, simulation, and therapeutic decision-making. Use these MCQs to test knowledge, identify weaknesses, and reinforce the quantitative reasoning central to rational drug therapy and dosage optimization.

Q1. Which PK/PD index best predicts the efficacy of a time-dependent antibiotic like beta-lactams?

  • Peak plasma concentration divided by MIC (Cmax/MIC)
  • 24-hour area under the concentration curve divided by MIC (AUC24/MIC)
  • Duration of time that free drug concentration remains above MIC during dosing interval (T>MIC)
  • Trough concentration divided by MIC (Cmin/MIC)

Correct Answer: Duration of time that free drug concentration remains above MIC during dosing interval (T>MIC)

Q2. In an Emax pharmacodynamic model, what does EC50 represent?

  • The maximum possible effect achievable with the drug
  • The concentration producing half of Emax
  • The slope of the concentration–effect curve at low concentrations
  • The concentration below which no effect occurs

Correct Answer: The concentration producing half of Emax

Q3. A counterclockwise hysteresis loop between plasma concentration and effect usually indicates which phenomenon?

  • Acute tolerance or tachyphylaxis reducing effect over time
  • Delayed distribution to the effect site or formation of active metabolite
  • Measurement error in concentration data
  • Rapid equilibration between plasma and effect site

Correct Answer: Delayed distribution to the effect site or formation of active metabolite

Q4. Which parameter describes sensitivity or steepness of a sigmoid concentration–response curve in the Hill equation?

  • Emax
  • EC50
  • Hill coefficient (gamma)
  • Baseline response (E0)

Correct Answer: Hill coefficient (gamma)

Q5. In indirect response PD models, inhibition of production of the response variable is best represented by which model structure?

  • Direct Emax model linking concentration to effect instantaneously
  • An effect compartment model with equilibration rate constant ke0
  • Inhibition of zero-order production rate (kin) of the response
  • Enhancement of first-order loss (kout) of the response

Correct Answer: Inhibition of zero-order production rate (kin) of the response

Q6. For concentration-dependent antibiotics like aminoglycosides, which PK/PD index correlates most with bacterial killing and clinical outcome?

  • Time above MIC (T>MIC)
  • Cmax/MIC
  • Minimum inhibitory concentration (MIC) alone
  • Steady-state trough concentration (Cmin)

Correct Answer: Cmax/MIC

Q7. What is the primary purpose of an effect‑compartment (biophase) model in PK/PD analysis?

  • To represent nonlinear elimination pathways in plasma
  • To convert total concentration to unbound concentration
  • To account for delay between plasma concentration and observed effect
  • To model drug–drug interactions at metabolic enzymes

Correct Answer: To account for delay between plasma concentration and observed effect

Q8. Target-mediated drug disposition (TMDD) influences PK/PD because:

  • It always simplifies the concentration–effect relationship to linear kinetics
  • High-affinity target binding can cause nonlinear PK and concentration-dependent PD
  • It only affects renal clearance, not pharmacodynamics
  • It eliminates the need for PK/PD modeling

Correct Answer: High-affinity target binding can cause nonlinear PK and concentration-dependent PD

Q9. In receptor theory, the presence of spare receptors implies which of the following?

  • Maximum effect requires occupancy of all receptors
  • Substantial effect can be achieved with less than full receptor occupancy
  • EC50 equals receptor dissociation constant (Kd)
  • Drug potency is solely determined by pharmacokinetics

Correct Answer: Substantial effect can be achieved with less than full receptor occupancy

Q10. When performing Monte Carlo simulations for antibiotic PTA (probability of target attainment), which input is MOST critical?

  • Precision of the spectrophotometric assay used in MIC testing
  • Distributions of PK parameters, MIC distribution for pathogens, and PD target
  • Patient satisfaction scores from clinical trials
  • Manufacturing batch-to-batch variability of the drug

Correct Answer: Distributions of PK parameters, MIC distribution for pathogens, and PD target

Q11. A clockwise hysteresis loop between plasma concentration and effect suggests which of the following?

  • Formation of an active metabolite causing delayed effect
  • Tolerance or acute decrease in response despite maintained concentration
  • Slow absorption leading to delayed peak concentrations
  • Incomplete drug sampling leading to erroneous PK profile

Correct Answer: Tolerance or acute decrease in response despite maintained concentration

Q12. Which covariate is most commonly incorporated into PK/PD models to scale clearance in adult populations?

  • Height alone
  • Body weight or body size descriptors
  • Color of eyes
  • Study site location

Correct Answer: Body weight or body size descriptors

Q13. In PK/PD modeling, the parameter ke0 is used to describe:

  • The elimination rate constant from plasma
  • The equilibration rate constant between plasma and effect compartment
  • The zero-order absorption rate
  • The intrinsic clearance of the liver

Correct Answer: The equilibration rate constant between plasma and effect compartment

Q14. For a drug with high protein binding, which statement is most relevant for PD effect prediction?

  • Total plasma concentration is always a reliable predictor of pharmacologic effect
  • Only unbound (free) concentration is pharmacologically active and should be considered
  • Protein binding has no effect on distribution to tissues
  • High protein binding increases the intrinsic potency of the drug

Correct Answer: Only unbound (free) concentration is pharmacologically active and should be considered

Q15. A sigmoid Emax model fit yields a Hill coefficient much greater than 1. This indicates:

  • A hyperbolic, non-cooperative binding relationship
  • Concentration–effect curve is extremely shallow
  • Positive cooperativity or steep concentration–effect relationship
  • No maximal effect can be achieved

Correct Answer: Positive cooperativity or steep concentration–effect relationship

Q16. Which PD endpoint is appropriate when modeling immunosuppressive drug action that reduces cytokine production over time?

  • Instantaneous direct Emax on blood pressure
  • Indirect response model with inhibition of cytokine production (kin)
  • Simple linear regression of dose versus peak concentration
  • Using MIC-based indices similar to antibiotics

Correct Answer: Indirect response model with inhibition of cytokine production (kin)

Q17. Population PK/PD modeling helps clinicians by:

  • Replacing the need for therapeutic drug monitoring entirely
  • Providing individualized dosing recommendations using covariates and Bayesian forecasting
  • Ensuring identical dosing for all patients regardless of covariates
  • Eliminating interindividual variability

Correct Answer: Providing individualized dosing recommendations using covariates and Bayesian forecasting

Q18. Which statement best describes the AUC/MIC index for antibiotics?

  • It reflects the time a drug concentration remains above MIC
  • It integrates both exposure and potency and is predictive for some concentration‑dependent antibiotics
  • It is irrelevant for slow-growing organisms and should not be used
  • It is identical to Cmax/MIC for all dosage regimens

Correct Answer: It integrates both exposure and potency and is predictive for some concentration‑dependent antibiotics

Q19. When a PD model includes interoccasion variability (IOV), this accounts for:

  • Between-subject differences that never change across occasions
  • Within-subject changes in PK/PD parameters between dosing occasions
  • Analytical assay variability only
  • Long-term population trends that are constant

Correct Answer: Within-subject changes in PK/PD parameters between dosing occasions

Q20. Which approach is most appropriate to evaluate if a PK/PD model adequately predicts observed data?

  • Comparing only the mean predicted concentration to mean observed concentration
  • Performed visual predictive checks (VPC) and posterior predictive checks including percentiles
  • Relying solely on p-values from stepwise covariate selection
  • Using only goodness-of-fit plots for one subject

Correct Answer: Performed visual predictive checks (VPC) and posterior predictive checks including percentiles

Author

  • G S Sachin Author Pharmacy Freak
    : Author

    G S Sachin is a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. He holds a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research and creates clear, accurate educational content on pharmacology, drug mechanisms of action, pharmacist learning, and GPAT exam preparation.

    Mail- Sachin@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators